This lack of sensitivity of NfL (and GFAP) in differentiating between sporadic bvFTD and late-onset PPD shows the necessity of finding a disease-specific biomarker for bvFTD. Here, GFAP is linked to progressive pseudorheumatoid arthropathy of childhood.